1.
Emerg Infect Dis
; 28(7): 1531-1533, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1902886
ABSTRACT
Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.